Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy | Zendy

Sato Ken | Zendy; Yamazaki Yuichi | Zendy; Kanayama Yuki | Zendy; Uehara Daisuke | Zendy; Tojima Hiroki | Zendy; Suga Takayoshi | Zendy; Kakizaki Satoru | Zendy; Sohara Naondo | Zendy; Horiguchi Norio | Zendy; Uraoka Toshio | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy

Author(s) -

Sato Ken,

Yamazaki Yuichi,

Kanayama Yuki,

Uehara Daisuke,

Tojima Hiroki,

Suga Takayoshi,

Kakizaki Satoru,

Sohara Naondo,

Horiguchi Norio,

Uraoka Toshio

Publication year - 2022

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.5690

Subject(s) - medicine , antiviral therapy , chronic hepatitis , adverse effect , hepatitis c , virology , virus

Three Japanese adolescents with chronic hepatitis C were treated by direct‐acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and their mothers were improved after DAA therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research